Trained as a scientific programmer, I worked on war game software for NORAD (North American Air Defense) and statistical software for Abbott Labs. For most of my 40-year career developed and sold financial and accounting software.
Was principal or founder of 3 small (5-30 employees) software companies.
Wrote a book on public pensions and a play that won an award in Writer Digest Magazine's annual writers competition, a contest that draws over 10,000 entries a year.
Michael Kramer is the founder and PM of MCM.
Michael Kramer is a thematic growth investor. He likes to think about themes in society and find long term equity investments that fit those themes.
Michael is the founding member of Mott Capital Management, LLC in 2014. Prior to MCM Michael spent the previous 10 years working as a domestic and international equity trader. During this time he was responsible for handling trades in some of the most illiquid equities. Additionally, Michael has experience trading in some of the most exotic foreign markets.
Mott Capital Management is a Thematic Growth investor using themes and trends in life to find exciting growth stories. Once we find a theme we want to capitalize on we begin searching for products that interact with the end user. From there we begin the company search process. We are long-term because that is our edge. We understand and recognize when events are critical and when they are not. We also believe it is a way to neutralize market volatility.
B.S. Psychology University of Missouri-Columbia
MBA University of Missouri-Columbia
Full time investor looking to capitalize on market overreactions and looking for value where others see nothing but wreckage. Long term buys and short term trades to build wealth.
Retired financial services financial analyst. Also experienced in structuring commercial real estate, leasing, wide variety of retail store and wholesale transactions I am Investing for my own portfolio
The majority of the comments I make are for stocks I own or have taken positions in the past long or short.
(Unlike many SA authors or commenters, I personally have money at stake in the majority of discussions I participate on SA and am not advising others in any professional capacity. Don't invest anything on my word, check it out for yourself. If you are risk adverse, hire a financial advisor.)
MagicDiligence provides useful, simple, and effective stock screening tools inspired by Joel Greenblatt's Magic Formula® Investing methodology. Our Spells give value and growth investors a list of great stock candidates every day, and our advanced Spell Caster lets you create the Magic-style stock screen you've always wanted! Learn more about our exclusive set of investing tools today!
Spent my career creating and commercializing semiconductor technologies for the convergence of wireless, mobility and consumer electronics in engineering, marketing and executive roles. Ironically, I tend to stay away from my career market as an investor, tending towards momentum stocks and now trying to increase my understanding of the use of options in this group.
I'm the author of six published books, an investor, and a cancer survivor. I got my start thirty-two years ago ghost-writing for a UCLA econ. prof who owned a popular stock-picking newsletter. I have been extensively involved in clinical research (consulted with various medical colleges on new technologies) as well as a speaker in post-doctoral continuing ed in the US, UK, and Canada. Right now, I'm re-editing books for publication and writing articles on Seeking Alpha for others who (like me) enjoy doing extensive investment research and profiting from it.
*************Original User account: 17741882***********************
General : Aspiring Equity Analyst with 7 years of professional and personal investment experience. Primary focus is Value and Growth both domestic and abroad (Europe and Latin America)
Professional Experience: Hedge Fund Assurance and Valuation Services ( AUM 100M - 10B). Exposure to almost every investment strategy and product on the market. Strategies ranged from typical Long/Short Equity & Structured Products such as MBS and CDOs, all the way to reinsurance funds trading catastrophe linked bonds.
Licenses: CPA (NJ) Certified Public Accountant
CFA Candidate - Level 1 June 2017
Very proud Rutgers Graduate- New Brunswick Campus - GO Scarlet Knights ! -
Major: Bachelor's of Accounting
SevenSeas Investment Research was created to provide investors with honest, deeply considered, detailed, passionately conducted, straight forward, value focused, fundamental investment research on a variety of asset classes and market topics.
I use a combination of traditional value focused fundamental research and a proprietary method of stock selection that can be adjusted to meet a dynamic mixture of different risk tolerances, and various other investor criteria to construct concentrated and unique portfolios to any given individual's investment needs.
My deep knowledge of Alternative Investments and Accounting (both GAAP & IFRS), as well as my exposure to dozens of successful hedge fund portfolios and complex investment securities, provided me with a unique perspective few obtain of a side of the market unseen by the retail investor. I wish to share my passion and knowledge for the markets that has grown to an obsession over the last 7 years with the SA community, to bring value to investors ranging from beginners, all the way to seasoned professionals, and network with the thousands of talented individuals from around the world who come to the platform seeking the same objectives.
My overall mission is to provide readers with valuable research to assist them in making wise investment decisions. All articles are my own personal views, and do not constitute investment advice. **Please be sure to contact your own investment professional when considering purchasing an investment.
SevenSeas will remain dedicated to providing a complete, and consistent level of work and appreciation for the readers. The highest standards of ethics and professionalism will be displayed at all times. I welcome all feedback and can be reached via direct messaging. Best of luck to all, and I hope you enjoy the work.
Zach is a biotech investor with PhD training in Biochemistry and Molecular Biology. In real life, he is a scientific writer specializing in continuing medical education. He hopes to provide a crucial piece of total due diligence as well as interesting insight into clinical findings that may impact readers' portfolios and lives.
I only look at stocks that have the possibility to double over a twelve month period and stocks in which the risk/reward ratio payout is high. In addition I focus on swing trade opportunities.
I focus more on valuations and risk/reward metrics as opposed to what make companies tick.
I have been a professional investor for over 20 years and during the past several years an economics analyst and financial writer for capital.gr, the biggest economic news portal in Greece.
I have managed money from time to time and have also done some seed venture capital projects in the past.
I'm a financial auditor that holds a BA in accounting and a MBA. I'm interested in where value can be realized. This could be a small or large cap company selling at favorable EV/EBIT or a special situation/event driven investments. Warren Buffet once said, "You have to turn over a lot of rocks to find those little anomalies" and I hope to do just that.
The author is an independent trader and investor specialising in analysis of stocks, foreign exchange and market indices.
When it comes to long-term stock investing, the author looks for companies that either a) appear to be undervalued/mispriced relative to their free cash flow/earnings growth, b) may trade at a premium but have sufficiently high rate of growth and prospects that would justify investment.
General Disclaimer: Please note that the information offered in the author's articles is strictly on an "as is" basis. The author is not aware of your financial circumstances or investment profile, and therefore any information from the author's articles should not be considered investment advice or a recommendation to buy or sell. The author is not a qualified investment advisor, and it is the reader's responsibility to seek professional advice before buying or selling securities. While the author makes every effort to verify all details reported on across every article, investors are responsible for conducting their own due diligence. Past performance does not guarantee future returns.
To follow me click the "Follow" button! (Easy right?)
Kumquat Research is a college student and fund manager who has been investing for 4 years. He writes mostly about the technology sector and about event-driven and momentum opportunities across various industries and sectors. He is currently studying for degrees in both finance and computer science at the University of Maryland. Some of his interests include technology, programming, drumming, video games (developing and playing) and astronomy. Articles written and comments posted by Kumquat Research are NOT financial or investment advice, and only express his opinion. Do your own due diligence!
Shudeep Chandrasekhar is a business consultant by profession and a musician by passion. With extensive experience in senior management, he has a thorough understanding of the internal workings of various types of businesses and what makes them tick. A keen student of the human mind and its potential, Shudeep constantly strives to understand the decision-making processes that underline every major business move. An enthusiastic traveller, Shudeep has lived and worked in more than a dozen countries including the United States, the United Kingdom, the Netherlands, Japan, Oman and many more. He is a truly global personality and currently lives in the bustling coastal city of Chennai, India - his birthplace.
I am an individual investor with 30 years of experience. Along with my trading experience I have a BS Bus, BS CMIS, MBA, passed CPA exam and leadership experience at 3 different Fortune 500 companies. I have also purchased, financed, built up and sold a small business.
I tend to follow about 50 companies across all industries and consider "Risk Management" to be my greatest strength. Through a combination of risk management and trading I was able to avoid and prosper from the recession.
My expectation is to beat the S&P 500 return and take less risk. I have accomplished that for several years in a row.
I added stock and bond analysis to my IT consulting business at the request of a small cap investment specialist in 2002. For my own account I invest mainly in technology and biotechnology stocks, but occasionally I invest in industrial, retail and other stocks. My technology and investment web site is openicon.com. I still enjoy IT consulting and always have some sort of R&D project going on.
I usually write about airline, aerospace, transport and industrial stocks as I have followed these industries for many years, developed contacts and an in-depth understanding of their inner workings. I will post detailed analysis and a guide to most developments that occur at all stocks I regularly cover. Currently I cover most major U.S airlines, and aerospace firms. Over time I hope to expand my coverage of quality aerospace, airline, transport and industrial stocks.
One area I focus on is the airline industry. The airline industry is undergoing fundamental change, with only 4 major U.S airlines now, down from 12 just over 10 years ago. This consolidation has rationalized the industry and for the first time in history made it worthy of investing and making a profit in. All major U.S airlines with the exception of Southwest are still not investment grade and still have many hurdles ahead, leaving nice upside for investors willing to get into the industry at this stage.
In general, I love trading value stocks that I believe have significant upside compared to downside long term. I prefer medium cap companies with compelling value, growth, or momentum. I focus on a select list of quality stocks that I have rigorously vetted which I update weekly. I like to create high quality in depth articles on stocks that I am passionate about and hope they will be of help to other investors out there or those looking for ideas to get started.
I am an MBA finance who worked as a stock adviser in an NY-based brokerage firm from 2003 to 2012 covering tech stocks. Currently I am working in an Asia-based investment bank as a sell side analyst.
As an individual investor, I generally focus on companies undergoing transition. My investment approach involves deriving value from transition, such as companies changing their business model, turnaround stories, merger and acquisition opportunities, and spin-offs.
I immigrated to the US in 2006. I started investing in India in 1999 just when the Indian markets were taking off. India had its share of Irrational Exuberance and eventually I lost quite a bit in Tech stocks from 1999 to 2002. After that I slowly moved on to cyclical (capital goods, manufacturing) and financial services stocks. I didn't have any money in the US earlier so started investing only in late 2007 - almost at the peak. And that too in REITs and finance stocks because they gave good dividend yields. We all know too well what happened to those stocks in 2008.
Now, I am trying to invest in other areas and build a steady stream of income and growth. I hold more than 60 stocks and more than 90% of my holdings are dividend growth stocks. I am short TSLA, NFLX, CRM and AMZN.
I am now retired from the US pharma industry having spent over 33 years in the Mid-Atlantic corridor in Sales(Hospital mainly), Scientific Relations and Managed Care/LTC. I worked at BMY, Bayer/Miles Labs and SGP/MRK prior to early retirement..
Today I enjoy investing in Bio-Pharmas mostly, because it is what I know best!
I invest mostly in large companies such as BMY, PFE, MRK, GSK, and JNJ (love the divis) but I like the up and coming Bios like CLDX. Cancer and Immunotherapy intrigues me..so I have made that a major consideration since 2008....With BARDA,the GAIN act and QDIP Ive come to appreciate the Antibiotic cos.and have made them a major component of my LT strategy to build wealth while in Retirement....Ive invested in Trius(TSRX),CBST, CEMP, DRTX, TTPH, CTIX and just added AKAO.....
I manage personal monies and some family members..gratis of course!
I'm a tech columnist for TheStreet. I was previously responsible for Seeking Alpha's tech news coverage, as well as its Eye on Tech newsletter. Prior to that, I wrote for other financial sites and published independent investment research, primarily on tech companies.
I have a B.A. in Economics from Columbia University. I'm based out of San Diego, but grew up in Southern New Jersey. I play basketball and tennis in my spare time, am a long-time (and long-suffering) fan of Philadelphia's sports teams, and alternate daily between using an iPad Air, a Galaxy Note 3, and one or two Windows PCs.
Ashraf Eassa is a technology specialist with The Motley Fool. He writes mostly about technology stocks, but is especially interested in anything related to chips -- the semiconductor kind, that is.
I manage two investment strategies: LONG ONLY U.S. Equity & LONG SHORT U.S. Equity.
I utilize proprietary fundamental analysis and believe the key to value creation is sustainable and growth free cash flow.